Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Brain Disorders

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Brain Disorders in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (80.00)18.2507
2000's1 (20.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, MF; Ding, WL; Gu, HY; Hu, JJ; Liu, WC1
Feuerstein, GZ1
Basile, AS; Kustova, Y; Markey, SP; Morse, HC; Nishida, K; Sei, Y1
Endo, S; Hirashima, Y; Takaba, M; Takaku, A1
Bazan, NG; Doucet, JP1

Reviews

2 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Brain Disorders

ArticleYear
Platelet-activating factor: a case for its role in CNS function and brain injury.
    Journal of lipid mediators and cell signalling, 1996, Volume: 14, Issue:1-3

    Topics: Animals; Brain; Brain Diseases; Humans; Platelet Activating Factor

1996
Excitable membranes, lipid messengers, and immediate-early genes. Alteration of signal transduction in neuromodulation and neurotrauma.
    Molecular neurobiology, 1992,Winter, Volume: 6, Issue:4

    Topics: Animals; Brain; Brain Diseases; Brain Ischemia; Cell Membrane; Fatty Acids, Unsaturated; Humans; Membrane Lipids; Nervous System Diseases; Neurons; Oncogenes; Phospholipids; Platelet Activating Factor; Second Messenger Systems; Seizures; Signal Transduction; Synapses; Synaptic Transmission

1992

Other Studies

3 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Brain Disorders

ArticleYear
Lipopolysaccharide-induced cerebral inflammatory damage and the therapeutic effect of platelet activating factor receptor antagonist.
    Neuroscience bulletin, 2007, Volume: 23, Issue:5

    Topics: Animals; Behavior, Animal; Brain Diseases; Fibrinolytic Agents; Ginkgolides; Hippocampus; Immunohistochemistry; Inflammation; Lactones; Lipopolysaccharides; Maze Learning; Microglia; Microscopy, Electron, Transmission; Neurons; Platelet Activating Factor; Platelet Membrane Glycoproteins; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled

2007
Pentoxifylline decreases brain levels of platelet activating factor in murine AIDS.
    European journal of pharmacology, 1997, Apr-23, Volume: 325, Issue:1

    Topics: Animals; Brain; Brain Diseases; Leukemia Virus, Murine; Mice; Mice, Inbred C57BL; Murine Acquired Immunodeficiency Syndrome; Pentoxifylline; Phosphodiesterase Inhibitors; Platelet Activating Factor; Retroviridae Infections; Tumor Necrosis Factor-alpha; Tumor Virus Infections

1997
Administration of methylprednisolone acetate into the subdural cavity in an infant with subdural fluid collection. PAF is a good indicator of the efficacy of the treatment.
    Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery, 1998, Volume: 14, Issue:8

    Topics: Anti-Inflammatory Agents; Biomarkers; Brain Diseases; Cardiac Surgical Procedures; Drainage; Female; Humans; Infant; Intracranial Pressure; Methylprednisolone; Methylprednisolone Acetate; Platelet Activating Factor; Postoperative Complications; Subdural Effusion; Tomography, X-Ray Computed

1998